Despite its potential, targeting the ECM poses several challenges. The ECM is highly heterogeneous and dynamic, varying significantly between different tumor types and even within a single tumor. This complexity makes it difficult to design universal ECM-targeted therapies. Furthermore, the ECM plays essential roles in normal tissue function, raising concerns about the potential side effects of ECM-targeted treatments.
